The International Stroke Conf. begins todayThat means international coverage of the presentation to the Conference...international interest in Tuesdays webcast..and some international buying. It will be interesting to see more details....the big thing is that there is both safety and efficacy. That is what potential partners are looking for. We know there is international interest as the CEO spoke to Japanese and Korean companies last year...and no doubt they are following this treatment with interest as there is a huge stroke rate in their countries....and few if any alternatives!